Frequently Asked Questions

BOPPP is designed for patients with liver cirrhosis and small oesophageal varices. If you have liver cirrhosis and small oesophageal varices there is a Participant Information sheet that can be viewed here.

After reading this information sheet, if you are still interested in taking part, you will need to speak with the clinician dealing with your liver disease at the Hospital you are being treated at. To find out if the Hospital in charge of your liver disease is recruiting patients for BOPPP, please click here.

Sometimes we do not know which treatment is best.  To find out, we compare different treatments by putting patients into groups with each receiving a different treatment.  This would apply to anybody taking part in BOPPP. However, by taking part, you will be closely monitored for the duration of the trial and will be in regular contact with a Liver Unit Research Nurse. 

At the end of the study, we will provide every patient a non-technical summary of the trial results. This document will show if early treatment with beta-blockers reduces the risk of bleeding in patients with liver cirrhosis and small oesophageal varices. This will allow you, your Liver Consultant and General Practitioner make an informed decision about your best long term treatment option.

It is very important that your GP knows about your participation in BOPPP. This is because there may be developments in your health where your GP needs to know what medications you are taking to avoid unnecessary drug interactions that might make you feel worse.

After you are given your BOPPP medication, the Research Nurse at the Hospital treating your liver disease will write to your GP, telling them that you are in the BOPPP trial. The GP will be provided with a copy of the Participant Information Sheet that you read before you decided to take part.

Your GP may be contacted by the Hospital treating your liver disease if you experience any adverse event out side of hospital to obtain relevant information to make sure that the severity of the event and relationship to the BOPPP medication is assessed accordingly.

BOPPP is designed for patients with liver cirrhosis and small oesophageal varices. If you have liver cirrhosis and small oesophageal varices there is a Participant Information sheet that can be viewed here.

After reading this information sheet, if you are still interested in taking part, you will need to speak with the clinician dealing with your liver disease at the Hospital you are being treated at. To find out if the Hospital in charge of your liver disease is recruiting patients for BOPPP, please click here.

Sometimes we do not know which treatment is best.  To find out, we compare different treatments by putting patients into groups with each receiving a different treatment.  This would apply to anybody taking part in BOPPP. However, by taking part, you will be closely monitored for the duration of the trial and will be in regular contact with a Liver Unit Research Nurse. 

At the end of the study, we will provide every patient a non-technical summary of the trial results. This document will show if early treatment with beta-blockers reduces the risk of bleeding in patients with liver cirrhosis and small oesophageal varices. This will allow you, your Liver Consultant and General Practitioner make an informed decision about your best long term treatment option.

It is very important that your GP knows about your participation in BOPPP. This is because there may be developments in your health where your GP needs to know what medications you are taking to avoid unnecessary drug interactions that might make you feel worse.

After you are given your BOPPP medication, the Research Nurse at the Hospital treating your liver disease will write to your GP, telling them that you are in the BOPPP trial. The GP will be provided with a copy of the Participant Information Sheet that you read before you decided to take part.

Your GP may be contacted by the Hospital treating your liver disease if you experience any adverse event out side of hospital to obtain relevant information to make sure that the severity of the event and relationship to the BOPPP medication is assessed accordingly.

BOPPP is designed for patients with liver cirrhosis and small oesophageal varices. If you have liver cirrhosis and small oesophageal varices there is a Participant Information sheet that can be viewed here.

After reading this information sheet, if you are still interested in taking part, you will need to speak with the clinician dealing with your liver disease at the Hospital you are being treated at. To find out if the Hospital in charge of your liver disease is recruiting patients for BOPPP, please click here.

Sometimes we do not know which treatment is best.  To find out, we compare different treatments by putting patients into groups with each receiving a different treatment.  This would apply to anybody taking part in BOPPP. However, by taking part, you will be closely monitored for the duration of the trial and will be in regular contact with a Liver Unit Research Nurse. 

At the end of the study, we will provide every patient a non-technical summary of the trial results. This document will show if early treatment with beta-blockers reduces the risk of bleeding in patients with liver cirrhosis and small oesophageal varices. This will allow you, your Liver Consultant and General Practitioner make an informed decision about your best long term treatment option.

It is very important that your GP knows about your participation in BOPPP. This is because there may be developments in your health where your GP needs to know what medications you are taking to avoid unnecessary drug interactions that might make you feel worse.

After you are given your BOPPP medication, the Research Nurse at the Hospital treating your liver disease will write to your GP, telling them that you are in the BOPPP trial. The GP will be provided with a copy of the Participant Information Sheet that you read before you decided to take part.

Your GP may be contacted by the Hospital treating your liver disease if you experience any adverse event out side of hospital to obtain relevant information to make sure that the severity of the event and relationship to the BOPPP medication is assessed accordingly.

BOPPP is designed for patients with liver cirrhosis and small oesophageal varices. If you have liver cirrhosis and small oesophageal varices there is a Participant Information sheet that can be viewed here.

After reading this information sheet, if you are still interested in taking part, you will need to speak with the clinician dealing with your liver disease at the Hospital you are being treated at. To find out if the Hospital in charge of your liver disease is recruiting patients for BOPPP, please click here.

Sometimes we do not know which treatment is best.  To find out, we compare different treatments by putting patients into groups with each receiving a different treatment.  This would apply to anybody taking part in BOPPP. However, by taking part, you will be closely monitored for the duration of the trial and will be in regular contact with a Liver Unit Research Nurse. 

At the end of the study, we will provide every patient a non-technical summary of the trial results. This document will show if early treatment with beta-blockers reduces the risk of bleeding in patients with liver cirrhosis and small oesophageal varices. This will allow you, your Liver Consultant and General Practitioner make an informed decision about your best long term treatment option.

It is very important that your GP knows about your participation in BOPPP. This is because there may be developments in your health where your GP needs to know what medications you are taking to avoid unnecessary drug interactions that might make you feel worse.

After you are given your BOPPP medication, the Research Nurse at the Hospital treating your liver disease will write to your GP, telling them that you are in the BOPPP trial. The GP will be provided with a copy of the Participant Information Sheet that you read before you decided to take part.

Your GP may be contacted by the Hospital treating your liver disease if you experience any adverse event out side of hospital to obtain relevant information to make sure that the severity of the event and relationship to the BOPPP medication is assessed accordingly.

BOPPP is designed for patients with liver cirrhosis and small oesophageal varices. If you have liver cirrhosis and small oesophageal varices there is a Participant Information sheet that can be viewed here.

After reading this information sheet, if you are still interested in taking part, you will need to speak with the clinician dealing with your liver disease at the Hospital you are being treated at. To find out if the Hospital in charge of your liver disease is recruiting patients for BOPPP, please click here.

Sometimes we do not know which treatment is best.  To find out, we compare different treatments by putting patients into groups with each receiving a different treatment.  This would apply to anybody taking part in BOPPP. However, by taking part, you will be closely monitored for the duration of the trial and will be in regular contact with a Liver Unit Research Nurse. 

At the end of the study, we will provide every patient a non-technical summary of the trial results. This document will show if early treatment with beta-blockers reduces the risk of bleeding in patients with liver cirrhosis and small oesophageal varices. This will allow you, your Liver Consultant and General Practitioner make an informed decision about your best long term treatment option.

It is very important that your GP knows about your participation in BOPPP. This is because there may be developments in your health where your GP needs to know what medications you are taking to avoid unnecessary drug interactions that might make you feel worse.

After you are given your BOPPP medication, the Research Nurse at the Hospital treating your liver disease will write to your GP, telling them that you are in the BOPPP trial. The GP will be provided with a copy of the Participant Information Sheet that you read before you decided to take part.

Your GP may be contacted by the Hospital treating your liver disease if you experience any adverse event out side of hospital to obtain relevant information to make sure that the severity of the event and relationship to the BOPPP medication is assessed accordingly.

BOPPP is designed for patients with liver cirrhosis and small oesophageal varices. If you have liver cirrhosis and small oesophageal varices there is a Participant Information sheet that can be viewed here.

After reading this information sheet, if you are still interested in taking part, you will need to speak with the clinician dealing with your liver disease at the Hospital you are being treated at. To find out if the Hospital in charge of your liver disease is recruiting patients for BOPPP, please click here.

Sometimes we do not know which treatment is best.  To find out, we compare different treatments by putting patients into groups with each receiving a different treatment.  This would apply to anybody taking part in BOPPP. However, by taking part, you will be closely monitored for the duration of the trial and will be in regular contact with a Liver Unit Research Nurse. 

At the end of the study, we will provide every patient a non-technical summary of the trial results. This document will show if early treatment with beta-blockers reduces the risk of bleeding in patients with liver cirrhosis and small oesophageal varices. This will allow you, your Liver Consultant and General Practitioner make an informed decision about your best long term treatment option.

It is very important that your GP knows about your participation in BOPPP. This is because there may be developments in your health where your GP needs to know what medications you are taking to avoid unnecessary drug interactions that might make you feel worse.

After you are given your BOPPP medication, the Research Nurse at the Hospital treating your liver disease will write to your GP, telling them that you are in the BOPPP trial. The GP will be provided with a copy of the Participant Information Sheet that you read before you decided to take part.

Your GP may be contacted by the Hospital treating your liver disease if you experience any adverse event out side of hospital to obtain relevant information to make sure that the severity of the event and relationship to the BOPPP medication is assessed accordingly.

BOPPP is designed for patients with liver cirrhosis and small oesophageal varices. If you have liver cirrhosis and small oesophageal varices there is a Participant Information sheet that can be viewed here.

After reading this information sheet, if you are still interested in taking part, you will need to speak with the clinician dealing with your liver disease at the Hospital you are being treated at. To find out if the Hospital in charge of your liver disease is recruiting patients for BOPPP, please click here.

Sometimes we do not know which treatment is best.  To find out, we compare different treatments by putting patients into groups with each receiving a different treatment.  This would apply to anybody taking part in BOPPP. However, by taking part, you will be closely monitored for the duration of the trial and will be in regular contact with a Liver Unit Research Nurse. 

At the end of the study, we will provide every patient a non-technical summary of the trial results. This document will show if early treatment with beta-blockers reduces the risk of bleeding in patients with liver cirrhosis and small oesophageal varices. This will allow you, your Liver Consultant and General Practitioner make an informed decision about your best long term treatment option.

It is very important that your GP knows about your participation in BOPPP. This is because there may be developments in your health where your GP needs to know what medications you are taking to avoid unnecessary drug interactions that might make you feel worse.

After you are given your BOPPP medication, the Research Nurse at the Hospital treating your liver disease will write to your GP, telling them that you are in the BOPPP trial. The GP will be provided with a copy of the Participant Information Sheet that you read before you decided to take part.

Your GP may be contacted by the Hospital treating your liver disease if you experience any adverse event out side of hospital to obtain relevant information to make sure that the severity of the event and relationship to the BOPPP medication is assessed accordingly.

BOPPP is designed for patients with liver cirrhosis and small oesophageal varices. If you have liver cirrhosis and small oesophageal varices there is a Participant Information sheet that can be viewed here.

After reading this information sheet, if you are still interested in taking part, you will need to speak with the clinician dealing with your liver disease at the Hospital you are being treated at. To find out if the Hospital in charge of your liver disease is recruiting patients for BOPPP, please click here.

Sometimes we do not know which treatment is best.  To find out, we compare different treatments by putting patients into groups with each receiving a different treatment.  This would apply to anybody taking part in BOPPP. However, by taking part, you will be closely monitored for the duration of the trial and will be in regular contact with a Liver Unit Research Nurse. 

At the end of the study, we will provide every patient a non-technical summary of the trial results. This document will show if early treatment with beta-blockers reduces the risk of bleeding in patients with liver cirrhosis and small oesophageal varices. This will allow you, your Liver Consultant and General Practitioner make an informed decision about your best long term treatment option.

It is very important that your GP knows about your participation in BOPPP. This is because there may be developments in your health where your GP needs to know what medications you are taking to avoid unnecessary drug interactions that might make you feel worse.

After you are given your BOPPP medication, the Research Nurse at the Hospital treating your liver disease will write to your GP, telling them that you are in the BOPPP trial. The GP will be provided with a copy of the Participant Information Sheet that you read before you decided to take part.

Your GP may be contacted by the Hospital treating your liver disease if you experience any adverse event out side of hospital to obtain relevant information to make sure that the severity of the event and relationship to the BOPPP medication is assessed accordingly.

BOPPP is designed for patients with liver cirrhosis and small oesophageal varices. If you have liver cirrhosis and small oesophageal varices there is a Participant Information sheet that can be viewed here.

After reading this information sheet, if you are still interested in taking part, you will need to speak with the clinician dealing with your liver disease at the Hospital you are being treated at. To find out if the Hospital in charge of your liver disease is recruiting patients for BOPPP, please click here.

Sometimes we do not know which treatment is best.  To find out, we compare different treatments by putting patients into groups with each receiving a different treatment.  This would apply to anybody taking part in BOPPP. However, by taking part, you will be closely monitored for the duration of the trial and will be in regular contact with a Liver Unit Research Nurse. 

At the end of the study, we will provide every patient a non-technical summary of the trial results. This document will show if early treatment with beta-blockers reduces the risk of bleeding in patients with liver cirrhosis and small oesophageal varices. This will allow you, your Liver Consultant and General Practitioner make an informed decision about your best long term treatment option.

It is very important that your GP knows about your participation in BOPPP. This is because there may be developments in your health where your GP needs to know what medications you are taking to avoid unnecessary drug interactions that might make you feel worse.

After you are given your BOPPP medication, the Research Nurse at the Hospital treating your liver disease will write to your GP, telling them that you are in the BOPPP trial. The GP will be provided with a copy of the Participant Information Sheet that you read before you decided to take part.

Your GP may be contacted by the Hospital treating your liver disease if you experience any adverse event out side of hospital to obtain relevant information to make sure that the severity of the event and relationship to the BOPPP medication is assessed accordingly.

BOPPP is designed for patients with liver cirrhosis and small oesophageal varices. If you have liver cirrhosis and small oesophageal varices there is a Participant Information sheet that can be viewed here.

After reading this information sheet, if you are still interested in taking part, you will need to speak with the clinician dealing with your liver disease at the Hospital you are being treated at. To find out if the Hospital in charge of your liver disease is recruiting patients for BOPPP, please click here.

Sometimes we do not know which treatment is best.  To find out, we compare different treatments by putting patients into groups with each receiving a different treatment.  This would apply to anybody taking part in BOPPP. However, by taking part, you will be closely monitored for the duration of the trial and will be in regular contact with a Liver Unit Research Nurse. 

At the end of the study, we will provide every patient a non-technical summary of the trial results. This document will show if early treatment with beta-blockers reduces the risk of bleeding in patients with liver cirrhosis and small oesophageal varices. This will allow you, your Liver Consultant and General Practitioner make an informed decision about your best long term treatment option.

It is very important that your GP knows about your participation in BOPPP. This is because there may be developments in your health where your GP needs to know what medications you are taking to avoid unnecessary drug interactions that might make you feel worse.

After you are given your BOPPP medication, the Research Nurse at the Hospital treating your liver disease will write to your GP, telling them that you are in the BOPPP trial. The GP will be provided with a copy of the Participant Information Sheet that you read before you decided to take part.

Your GP may be contacted by the Hospital treating your liver disease if you experience any adverse event out side of hospital to obtain relevant information to make sure that the severity of the event and relationship to the BOPPP medication is assessed accordingly.

BOPPP is designed for patients with liver cirrhosis and small oesophageal varices. If you have liver cirrhosis and small oesophageal varices there is a Participant Information sheet that can be viewed here.

After reading this information sheet, if you are still interested in taking part, you will need to speak with the clinician dealing with your liver disease at the Hospital you are being treated at. To find out if the Hospital in charge of your liver disease is recruiting patients for BOPPP, please click here.

Sometimes we do not know which treatment is best.  To find out, we compare different treatments by putting patients into groups with each receiving a different treatment.  This would apply to anybody taking part in BOPPP. However, by taking part, you will be closely monitored for the duration of the trial and will be in regular contact with a Liver Unit Research Nurse. 

At the end of the study, we will provide every patient a non-technical summary of the trial results. This document will show if early treatment with beta-blockers reduces the risk of bleeding in patients with liver cirrhosis and small oesophageal varices. This will allow you, your Liver Consultant and General Practitioner make an informed decision about your best long term treatment option.

It is very important that your GP knows about your participation in BOPPP. This is because there may be developments in your health where your GP needs to know what medications you are taking to avoid unnecessary drug interactions that might make you feel worse.

After you are given your BOPPP medication, the Research Nurse at the Hospital treating your liver disease will write to your GP, telling them that you are in the BOPPP trial. The GP will be provided with a copy of the Participant Information Sheet that you read before you decided to take part.

Your GP may be contacted by the Hospital treating your liver disease if you experience any adverse event out side of hospital to obtain relevant information to make sure that the severity of the event and relationship to the BOPPP medication is assessed accordingly.

BOPPP is designed for patients with liver cirrhosis and small oesophageal varices. If you have liver cirrhosis and small oesophageal varices there is a Participant Information sheet that can be viewed here.

After reading this information sheet, if you are still interested in taking part, you will need to speak with the clinician dealing with your liver disease at the Hospital you are being treated at. To find out if the Hospital in charge of your liver disease is recruiting patients for BOPPP, please click here.

Sometimes we do not know which treatment is best.  To find out, we compare different treatments by putting patients into groups with each receiving a different treatment.  This would apply to anybody taking part in BOPPP. However, by taking part, you will be closely monitored for the duration of the trial and will be in regular contact with a Liver Unit Research Nurse. 

At the end of the study, we will provide every patient a non-technical summary of the trial results. This document will show if early treatment with beta-blockers reduces the risk of bleeding in patients with liver cirrhosis and small oesophageal varices. This will allow you, your Liver Consultant and General Practitioner make an informed decision about your best long term treatment option.

It is very important that your GP knows about your participation in BOPPP. This is because there may be developments in your health where your GP needs to know what medications you are taking to avoid unnecessary drug interactions that might make you feel worse.

After you are given your BOPPP medication, the Research Nurse at the Hospital treating your liver disease will write to your GP, telling them that you are in the BOPPP trial. The GP will be provided with a copy of the Participant Information Sheet that you read before you decided to take part.

Your GP may be contacted by the Hospital treating your liver disease if you experience any adverse event out side of hospital to obtain relevant information to make sure that the severity of the event and relationship to the BOPPP medication is assessed accordingly.